D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 71 Citations 25,895 281 World Ranking 16723 National Ranking 8498

Overview

What are the main themes of his work throughout his whole career to date

Hilliard F. Seigler performs multidisciplinary study in the fields of Cancer research and Metastasis via his papers. He carries out multidisciplinary research, doing studies in Metastasis and Micrometastasis. As part of his studies on Micrometastasis, he frequently links adjacent subjects like Breast cancer. He frequently studies issues relating to Sentinel node and Breast cancer. His work on Cancer expands to the thematically related Sentinel node. He undertakes multidisciplinary investigations into Cancer and Cancer research in his work. His Internal medicine study frequently draws connections to adjacent fields such as Distension. Hilliard F. Seigler merges Melanoma with Fibrosarcoma in his research. In his work, he performs multidisciplinary research in Fibrosarcoma and Melanoma.

Hilliard F. Seigler most often published in these fields:

  • Cancer research (66.67%)
  • Internal medicine (66.67%)
  • Melanoma (66.67%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Mutations of the BRAF gene in human cancer

Helen Davies;Graham R. Bignell;Charles Cox;Philip Stephens.
Nature (2002)

11646 Citations

The orderly progression of melanoma nodal metastases.

Douglas Reintgen;C. Cruse;Karen Wells;Claudia Berman.
Annals of Surgery (1994)

889 Citations

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma

John H. Sampson;James H. Carter;Allan H. Friedman;Hilliard F. Seigler.
Journal of Neurosurgery (1998)

613 Citations

Preoperative Radiation and Chemotherapy in the Treatment of Adenocarcinoma of the Rectum

Ravi S. Chari;Douglas S. Tyler;Mitchell Steven Anscher;Linda Russell.
Annals of Surgery (1995)

375 Citations

The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.

T L Darrow;C L Slingluff;H F Seigler.
Journal of Immunology (1989)

311 Citations

ANALYSIS OF 945 CASES OF PULMONARY METASTATIC MELANOMA

David H. Harpole;Cheryl M. Johnson;Walter G. Wolfe;Stephen L. George.
The Journal of Thoracic and Cardiovascular Surgery (1992)

283 Citations

Melanoma, a tumor based on a mutant stem cell?

James M. Grichnik;James A. Burch;Ryan D. Schulteis;Siqing Shan.
Journal of Investigative Dermatology (2006)

250 Citations

Lethal "thin" malignant melanoma. Identifying patients at risk.

Craig L. Slingluff;Robin T. Vollmer;Douglas S. Reintgen;Hilliard F. Seigler.
Annals of Surgery (1988)

249 Citations

Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.

Douglas S. Reintgen;Edwin B. Cox;Kenneth S. McCARTY;Robin T. Vollmer.
Annals of Surgery (1983)

246 Citations

Late recurrence of malignant melanoma. Analysis of 168 patients.

Nancy J. Crowley;Hilliard F. Seigler.
Annals of Surgery (1990)

235 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hilliard F. Seigler

John F. Thompson

John F. Thompson

University of Sydney

Publications: 228

Richard A. Scolyer

Richard A. Scolyer

Royal Prince Alfred Hospital

Publications: 140

Keith T. Flaherty

Keith T. Flaherty

Harvard University

Publications: 124

Donald L. Morton

Donald L. Morton

Saint John's Health Center

Publications: 96

Claus Garbe

Claus Garbe

University of Tübingen

Publications: 92

Vernon K. Sondak

Vernon K. Sondak

University of South Florida

Publications: 85

Merrick I. Ross

Merrick I. Ross

The University of Texas MD Anderson Cancer Center

Publications: 79

Douglas S. Reintgen

Douglas S. Reintgen

University of South Florida

Publications: 79

Meenhard Herlyn

Meenhard Herlyn

The Wistar Institute

Publications: 69

Dirk Schadendorf

Dirk Schadendorf

University of Duisburg-Essen

Publications: 69

Georgina V. Long

Georgina V. Long

University of Sydney

Publications: 64

Jeffrey E. Gershenwald

Jeffrey E. Gershenwald

The University of Texas MD Anderson Cancer Center

Publications: 64

Richard Marais

Richard Marais

University of Manchester

Publications: 62

Paolo A. Ascierto

Paolo A. Ascierto

National Institutes of Health

Publications: 59

Michael A. Davies

Michael A. Davies

The University of Texas MD Anderson Cancer Center

Publications: 57

Reinhard Dummer

Reinhard Dummer

University of Zurich

Publications: 57

Trending Scientists

Jeff Kramer

Jeff Kramer

Imperial College London

Suprateek Sarker

Suprateek Sarker

University of Virginia

James Bushnell

James Bushnell

University of California, Davis

Simon P. Anderson

Simon P. Anderson

University of Virginia

Arnon Amir

Arnon Amir

IBM (United States)

Hongwen He

Hongwen He

Beijing Institute of Technology

Jan Beck

Jan Beck

University of Colorado Boulder

Kun Yan Zhu

Kun Yan Zhu

Kansas State University

Mark C. Steinhoff

Mark C. Steinhoff

Cincinnati Children's Hospital Medical Center

Donald R. MacGorman

Donald R. MacGorman

University of Oklahoma

Valtteri Kaasinen

Valtteri Kaasinen

Turku University Hospital

Toshiya Murai

Toshiya Murai

Kyoto University

Gary D. Slade

Gary D. Slade

University of North Carolina at Chapel Hill

Khurram Nasir

Khurram Nasir

Houston Methodist

Shoichiro Tsugane

Shoichiro Tsugane

National Cancer Research Institute, UK

Robert B. Avery

Robert B. Avery

Federal Reserve System

Something went wrong. Please try again later.